Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FCMTQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,250
Award facts
- Contract value 100% obligated
- $16,249.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order from the Defense Logistics Agency valued at $16,249.95 for Stelara 90 mg/ml syringes. The contract, awarded on June 2, 2025, with an ultimate completion date of June 24, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at approximately $500 million and extends through November 2026.
The SPE2DB contract enables the Defense Logistics Agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting medical supply needs across military health facilities worldwide. Stelara, a biologic medication used in treating autoimmune conditions, represents one of many specialty pharmaceutical products within the company's extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables. DMS Pharmaceutical Group's status as an established federal supplier demonstrates consistent capability in delivering critical pharmaceutical products to Department of Defense healthcare sites across the country.
Quick answers
Who was awarded contract SPE2DB25FCMTQ?
SPE2DB25FCMTQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FCMTQ worth?
The government has obligated $16,250 on SPE2DB25FCMTQ.
Is contract SPE2DB25FCMTQ an order under another contract?
Yes. SPE2DB25FCMTQ is a delivery order under SPE2DB24D9144, an indefinite delivery contract.
Was contract SPE2DB25FCMTQ competed?
The extent of competition for SPE2DB25FCMTQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award